1. Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet. 2005. 366:665–675.
Article
2. Plouin PF, Degoulet P, Tugayé A, Ducrocq MB, Ménard J. [Screening for phaeochromocytoma: in which hypertensive patients? A semiological study of 2585 patients, including 11 with phaeochromocytoma (author's transl). Nouv Presse Med. 1981. 10:869–872.
3. Schifferdecker B, Kodali D, Hausner E, Aragam J. Adrenergic shock-an overlooked clinical entity? Cardiol Rev. 2005. 13:69–72.
4. Sardesai SH, Mourant AJ, Sivathandon Y, Farrow R, Gibbons DO. Phaeochromocytoma and catecholamine induced cardiomyopathy presenting as heart failure. Br Heart J. 1990. 63:234–237.
Article
5. Huddle KR, Kalliatakis B, Skoularigis J. Pheochromocytoma associated with clinical and echocardiographic features simulating hypertrophic obstructive cardiomyopathy. Chest. 1996. 109:1394–1397.
Article
6. Gupta KK. Letter: Phaeochromocytoma and myocardial infarction. Lancet. 1975. 1:281–282.
7. Nirgiotis JG, Andrassy RJ. Pheochromocytoma and acute myocardial infarction. South Med J. 1990. 83:1478–1480.
Article
8. Szakacs JE, Cannon A. L-Norepinephrine myocarditis. Am J Clin Pathol. 1958. 30:425–434.
Article
9. Kline IK. Myocardial alterations associated with pheochromocytomas. Am J Pathol. 1961. 38:539–551.
10. Seeley E WG. The heart in endocrine disorders. Braunwald's heart disease: a textbook of cardiovascular medicine. 2005. 7th ed. New York: W.B. Saunders Co.;2063–2064.
.
11. Sayer WJ, Moser M, Mattingly TW. Pheochromocytoma and the abnormal electrocardiogram. Am Heart J. 1954. 48:42–53.
Article
12. Shimizu K, Miura Y, Meguro Y, Noshio T, Ohzeki T, Kusakari T, Akama H, Watanabe T, Honma H, Imai Y. QT prolongation with torsade de pointes in pheochromocytoma. Am Heart J. 1992. 124:235–239.
Article
13. Haas GJ, Tzagournis M, Boudoulas H. Pheochromocytoma: catecholamine-mediated electrocardiographic changes mimicking ischemia. Am Heart J. 1988. 116:1363–1365.
Article
14. Cheng TO, Bashour TT. Striking electrocardiographic changes associated with pheochromocytoma. Masquerading as ischemic heart disease. Chest. 1976. 70:397–399.
15. McManus BM, Fleury TA, Roberts WC. Fatal catecholamine crisis in pheochromocytoma: curable cause of cardiac arrest. Am Heart J. 1981. 102:930–932.
Article
16. Delaney JP, Paritzky AZ. Necrosis of a pheochromocytoma with shock. N Engl J Med. 1969. 280:1394–1395.
Article
17. Duh QY. Evolving surgical management for patients with pheochromocytoma. J Clin Endocrinol Metab. 2001. 86:1477–1479.
Article
18. Dembitsky WP, Moreno-Cabral RJ, Adamson RM, Daily PO. Emergency resuscitation using portable extracorporeal membrane oxygenation. Ann Thorac Surg. 1993. 55:304–309.
Article
19. Chen YS, Wang MJ, Chou NK, Han YY, Chiu IS, Lin FY, Chu SH, Ko WJ. Rescue for acute myocarditis with shock by extracorporeal membrane oxygenation. Ann Thorac Surg. 1999. 68:2220–2224.
Article
20. Takagi S, Miyazaki S, Fujii T, Daikoku S, Sutani Y, Morii I, Yasuda S, Goto Y, Nonogi H. Dexamethasone-induced cardiogenic shock rescued by percutaneous cardiopulmonary support (PCPS) in a patient with pheochromocytoma. Jpn Circ J. 2000. 64:785–788.
Article
21. Shen WT, Sturgeon C, Clark OH, Duh QY, Kebebew E. Should pheochromocytoma size influence surgical approach? A comparison of 90 malignant and 60 benign pheochromocytomas. Surgery. 2004. 136:1129–1137.
Article